Archived articles

William moss

A person loads a syringe from a glass vial containing the Novavax vaccine while a promotional sign in the background reads 'Novavax'
COVID-19
What you need to know about the Novavax vaccine
Published June 16, 2022
Novavax uses a combination of spike proteins and an immune stimulant to provoke an immune response against the virus that causes COVID-19. Vaccine expert William Moss discusses its strengths and weaknesses ahead of its potential emergency use authorization.
A healthcare worker readies a COVID-19 vaccine at a vaccine clinic operated by Johns Hopkins at Port Discovery in February 2022
Coronavirus
Key COVID-19 metrics decline, but experts say it's far from over
Published Feb 28, 2022
COVID-19 is inching toward endemic status in the U.S., but a clear seasonal pattern has yet to emerge. Meanwhile less than 66% of the total population has been vaccinated.
White N95 masks with yellow straps are stacked in the foreground
Coronavirus
Experts discuss risks of ending mask mandates too soon
Published Feb 11, 2022
Indoor winter gatherings, low vaccination rates among eligible children are reasons for concern, according Hopkins experts
Medical personnel screen a patient in an ambulance
Coronavirus
COVID-19 cases surge but not deaths as pandemic enters third year
Published Jan 7, 2022
In briefing Friday, experts agree that vaccination is the reason behind the lower death rate despite the soaring number of people infected with COVID-19
Boxed Pfizer vaccines are shipped overseas
Q+A
Without global vaccinations, further variants ahead
Published Dec 21, 2021
Vaccine experts Anna Durbin and William Moss explain how vaccination prevents viral mutation, discuss remaining barriers to global vaccine access
Bill Moss and Jennifer Nuzzo
COVID-19 briefing
Omicron variant is likely everywhere, delta cases increasing
Published Dec 6, 2021
Delta remains dominant around the world while omicron emerges, though time will tell whether the new variant will challenge vaccine effectiveness
Child wearing a mask while sitting in their mother's lap gets a COVID-19 vaccine
Q+A
COVID vaccines have been OK'd for kids. Now what?
Published Nov 4, 2021
Emergency use authorization for Pfizer/BioNTech's vaccine is unlikely to lead to widespread vaccinations among the nation's 28 million 5- to 11-year-olds, Hopkins vaccine expert William Moss says
Coronavirus vaccine vials in the shape of Africa
Q+A
As Africa goes unvaccinated, U.S. remains awash in shots
Published Nov 2, 2021
Johns Hopkins vaccine expert William Moss discusses inequities in the race to vaccinate the world against COVID-19 and why the U.S. and other wealthy nations should help poorer countries catch up
Beth Blauer and William Moss
Coronavirus
COVID-19 this week: Booster shots and U.S. strategies
Published Oct 15, 2021
Johns Hopkins experts Beth Blauer and William Moss discuss booster shots, global vaccine supply strategies, data collection issues
COVID-19 vaccine vial
Q+A
Pfizer moves toward booster approval, vaccine for children
Published Sept 22, 2021
FDA, CDC expected to finalize decisions about Pfizer booster doses in same week the company announced that studies of its vaccine for children show promising results